Table 2. Paraoxonase-1 allele, genotype, and haplotype distributions of L55M and Q192R polymorphisms in patients and healthy individuals of the hypercholesterolemia family.
Characteristics (Allele/Genotypes) | Patients (n = 10) | Controls (n = 24) | p | |
---|---|---|---|---|
Alleles | L55 | 2 (10%) | 2 (4.2%) | 0.336 |
M55 | 18 (90%) | 46 (95.8%) | 0.927 | |
Q192 | 19 (95%) | 33 (68.7%) | 0.0164 | |
R192 | 1 (5%) | 15 (62%) | 0.998 | |
Genotypes | L55L55 | 0 (0%) | 0 (0%) | 1 |
L55M55 | 2 (20%) | 2 (8.3%) | 0.334 | |
M55M55 | 8 (80%) | 22 (91.7%) | 0.933 | |
Q192Q192 | 9 (90%) | 10 (41.7%) | 0.0113 | |
Q192R192 | 1 (10%) | 13 (54.2%) | 0.999 | |
R192R192 | 0 (0%) | 1 (4.2%) | 1 | |
Haplotypes | M55M55/Q192Q192 | 8 (80%) | 8 (33.3%) | 0.017 |
L55M55/Q192Q192 | 1 (10%) | 2 (8.3%) | 0.661 | |
L55M55/Q192R192 | 1 (10%) | 0 (0%) | 0.294 | |
M55M55/Q192R192 | 0 (0%) | 13 (54.2%) | 1 | |
M55M55/R192R192 | 0 (0%) | 1 (4.2%) | 1 |
p < 0.05 was considered statistically significant; data were analyzed using Fisher’s Exact Test.